🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused steps to tackle household expense challenges" in the upcoming financial statement.

In comments to media outlets, she noted that lowering price rises is a collective duty of both the administration and the central bank.

The UK's inflation rate is projected to be the highest among the Group of Seven developed nations this calendar year and next.

Potential Energy Bill Measures

Sources suggest the government could intervene to lower utility costs, for example by cutting the present 5% level of VAT applied on energy.

Another option is to cut some of the policy costs currently included in household expenses.

Budgetary Constraints and Expert Expectations

The administration will receive the latest draft from the independent fiscal watchdog, the OBR, on Monday, which will show how much room there is for such measures.

The view from the majority of economists is that Reeves will have to declare tax increases or budget cuts in order to meet her self-imposed borrowing rules.

Previously on the same day, calculations showed there was a £22 billion gap for the Treasury chief to resolve, which is at the lower end of projections.

"It is a collective job between the Bank of England and the administration to continue tackling some of the drivers of price increases," Reeves stated to the BBC in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and International Issues

While much of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not changed her vow to election pledges not to raise tax levels on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with growing geopolitical and trade issues for the Budget revenue measures, probably to be focused on those "wealthiest."

Global Economic Tensions

Commenting on concerns about the UK's commercial links with the Asian nation she said: "Our national security always come first."

Recent statement by China to tighten trade restrictions on rare earths and other resources that are key for high-technology production led US President the US President to suggest an additional 100% import tax on imports from the Asian country, increasing the risk of an all-out trade war between the two largest economies.

The US Treasury Secretary called China's action "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its battle with China, the Chancellor said she was "extremely troubled" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and generates additional headwinds."

"It is my opinion there are areas where we should challenge China, but there are also significant prospects to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."

The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Pricing and Investment

The Chancellor also recognized that the cost the National Health Service pays for drugs could increase as a result of ongoing talks with the US government and its drugs companies, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping projects in the UK, with several attributing the modest returns they are receiving.

Last month, the Science Minister said the cost the NHS pays for medicines would must go up to halt companies and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "We have seen due to the pricing regime, that medical research, innovative medicines have not been offered in the UK in the manner that they are in other European countries."

"We want to guarantee that patients receiving treatment from the National Health Service are able to receive the top essential medicines in the world. And so we are examining all of that, and... aiming to attract more capital into the UK."